Skip to content
Facebook Instagram Linkedin

LifeScienceHistory.com

History made daily

  • Home
  • DirectoryExpand
    • General Company Directory
    • CRO Directory
    • CMO Directory
    • Genealogy on Demand
  • CareersExpand
    • Find Your Job
    • Advertise Your Life Science Jobs
  • News and History
  • Cartoons
  • Small World
  • Earth is a RockExpand
    • Earth is a Rock
    • Earth is a Rock Lyrics
    • Earth is a Rock Lyrics Defined
LifeScienceHistory.com
History made daily
Home / 2020 - Page 18

Year: 2020

FDA amended EUA for Hologicメs Aptima SARS-CoV-2 assay to Include COVID-19 testing of asymptomatic individuals
COVID-19 | FDA | Life Science History

FDA amended EUA for Hologicメs Aptima SARS-CoV-2 assay to Include COVID-19 testing of asymptomatic individuals

On Oct. 6, 2020, Hologic announced that its Aptimaᆴ SARS-CoV-2 assay, which initially received Emergency Use Authorization (EUA)…

Read More FDA amended EUA for Hologicメs Aptima SARS-CoV-2 assay to Include COVID-19 testing of asymptomatic individualsContinue

Hologic Panther Platform and HIV-1 Quant assay used in ‘HIV Cure’ research
Biotechnology | Diagnostics | HIV | Non-Profit Research | Therapeutics

Hologic Panther Platform and HIV-1 Quant assay used in ‘HIV Cure’ research

On Oct. 6, 2020, Hologic announced that two studies in the Journal of Clinical Microbiology demonstrated the utility…

Read More Hologic Panther Platform and HIV-1 Quant assay used in ‘HIV Cure’ researchContinue

Broad and Brigham and Women’s Hospital launched COVID-19 surveillance study
Biotechnology | COVID-19 | Medical Device

Broad and Brigham and Women’s Hospital launched COVID-19 surveillance study

On Oct. 6, 2020, clinicians and researchers from Brigham and Women’s Hospital, the Broad Institute of MIT and…

Read More Broad and Brigham and Women’s Hospital launched COVID-19 surveillance studyContinue

BioNTech and Pfizer initiated a rolling submission to EMA for SARS-CoV-2 vaccine candidate BNT162b2
COVID-19 | Life Science History | Vaccine

BioNTech and Pfizer initiated a rolling submission to EMA for SARS-CoV-2 vaccine candidate BNT162b2

On Oct. 6, 2020, Pfizer and BioNTech announced initiation of a rolling submission to the European Medicines Agency…

Read More BioNTech and Pfizer initiated a rolling submission to EMA for SARS-CoV-2 vaccine candidate BNT162b2Continue

FDA awarded contract to Stanford University to perform in-depth analysis of tissue samples to learn how SARS-CoV-2 causes COVID-19
COVID-19 | FDA | Life Science History

FDA awarded contract to Stanford University to perform in-depth analysis of tissue samples to learn how SARS-CoV-2 causes COVID-19

On Oct. 5, 2020, the FDA awarded a research contract to the Stanford University School of Medicine to…

Read More FDA awarded contract to Stanford University to perform in-depth analysis of tissue samples to learn how SARS-CoV-2 causes COVID-19Continue

The Nobel Prize in Medicine for 2020 was awarded to Harvey J Alter, Michael Houghton and Charles M Rice
Biotechnology | Infectious Disease | Medicine

The Nobel Prize in Medicine for 2020 was awarded to Harvey J Alter, Michael Houghton and Charles M Rice

On Oct. 5, 2020, the Nobel Prize in Medicine 2020 was awarded to Harvey J. Alter, Michael Houghton…

Read More The Nobel Prize in Medicine for 2020 was awarded to Harvey J Alter, Michael Houghton and Charles M RiceContinue

The CDC updated ‘how COVID is spread’
CDC | COVID-19

The CDC updated ‘how COVID is spread’

On Oct. 5, 2020, the CDC announced the existence of published reports that showed limited, uncommon circumstances where…

Read More The CDC updated ‘how COVID is spread’Continue

Mateon initiated commercialization of Artshield
COVID-19 | Therapeutics

Mateon initiated commercialization of Artshield

On Oct. 5, 2020, Mateon Therapeutics announced that ArtiShieldTM had been approved for manufacture and marketing by the…

Read More Mateon initiated commercialization of ArtshieldContinue

Vaxxas announced $22 million award from U.S. Government to advance Vaxxas Needle-Free HD-MAP vaccine patch
Biotechnology | Infectious Disease | Influenza | Vaccine

Vaxxas announced $22 million award from U.S. Government to advance Vaxxas Needle-Free HD-MAP vaccine patch

On Oct. 5, 2020, Vaxxas announced a $22 million United States government award to support the deployment of…

Read More Vaxxas announced $22 million award from U.S. Government to advance Vaxxas Needle-Free HD-MAP vaccine patchContinue

CLEAR adds LabCorp COVID-19 test results to モHealth Passヤ mobile app
COVID-19 | Life Science History

CLEAR adds LabCorp COVID-19 test results to モHealth Passヤ mobile app

On Oct. 5, 2020, CLEAR, the secure identity company, and LabCorp announced a partnership to enable users of…

Read More CLEAR adds LabCorp COVID-19 test results to モHealth Passヤ mobile appContinue

CLEAR and Quest Diagnostics collaborated to integrate COVID-19 test results with “Health Pass” for safer environments
COVID-19 | Life Science History

CLEAR and Quest Diagnostics collaborated to integrate COVID-19 test results with “Health Pass” for safer environments

On Oct. 5, 2020, CLEAR, the secure identity company, and Quest Diagnostics announced a new collaboration that aimed…

Read More CLEAR and Quest Diagnostics collaborated to integrate COVID-19 test results with “Health Pass” for safer environmentsContinue

Bristol Myers Squibb to acquire MyoKardia for $131 billion in cash
Life Science History

Bristol Myers Squibb to acquire MyoKardia for $131 billion in cash

On Oct. 5, 2020, Bristol-Myers and MyoKardia announced a definitive merger agreement under which Bristol Myers Squibb will…

Read More Bristol Myers Squibb to acquire MyoKardia for $131 billion in cashContinue

Data from Corvus phase 1 study of CPI-006 continued to support its potential as treatment for COVID-19
Biotechnology | COVID-19 | FDA | Pharmaceutical

Data from Corvus phase 1 study of CPI-006 continued to support its potential as treatment for COVID-19

On Oct. 5, 2020, Corvus Pharmaceuticals announced that it has initiated a Phase 1 study to investigate a…

Read More Data from Corvus phase 1 study of CPI-006 continued to support its potential as treatment for COVID-19Continue

NIH awarded $138 million for studies on the prevention and treatment of Alzheimer’s disease
Life Science History

NIH awarded $138 million for studies on the prevention and treatment of Alzheimer’s disease

On Oct. 5, 2020, Joe Verghese, M.B.B.S., M.S., an international leader in aging and cognition research at Albert…

Read More NIH awarded $138 million for studies on the prevention and treatment of Alzheimer’s diseaseContinue

Fred Hutch opened COVID-19 clinical research center
Biotechnology | COVID-19 | Diagnostics | Infectious Disease

Fred Hutch opened COVID-19 clinical research center

On Oct. 5, 2020, the Fred Hutchinson Cancer Research Center announced the opening of the COVID-19 Clinical Research…

Read More Fred Hutch opened COVID-19 clinical research centerContinue

The Nobel Prize in Chemistry for 2021 was awarded to Benjamin List and David MacMillan
Life Science History

The Nobel Prize in Chemistry for 2021 was awarded to Benjamin List and David MacMillan

On Oct. 5, 2021, the Nobel Prize in Chemistry 2020 was awarded to Benjamin List and David MacMillan…

Read More The Nobel Prize in Chemistry for 2021 was awarded to Benjamin List and David MacMillanContinue

FDA approved drug combination for treating mesothelioma
FDA | Life Science History

FDA approved drug combination for treating mesothelioma

On Oct. 1, 2020, the FDA approved Opdivo (nivolumab) in combination with Yervoy (ipilimumab) for the first-line treatment…

Read More FDA approved drug combination for treating mesotheliomaContinue

COVID-19 vaccine AZD1222 clinical trial resumed in Japan, follows restart of trials in the UK, Brazil, South Africa and India
COVID-19 | Life Science History | Vaccine

COVID-19 vaccine AZD1222 clinical trial resumed in Japan, follows restart of trials in the UK, Brazil, South Africa and India

On Oct. 2, 2020, AstraZeneca announced the phase I/II clinical trial for the COVID-19 vaccine AZD1222 had resumed…

Read More COVID-19 vaccine AZD1222 clinical trial resumed in Japan, follows restart of trials in the UK, Brazil, South Africa and IndiaContinue

National Science Foundation announced investment of $40 million in future of US manufacturing
Life Science History

National Science Foundation announced investment of $40 million in future of US manufacturing

On Oct. 2, 2020, the National Science Foundation announced investments in 24 new projects to drive future manufacturing….

Read More National Science Foundation announced investment of $40 million in future of US manufacturingContinue

Yale PET Center received $102 million BRAIN Initiative grant to build new scanner
Medical Device

Yale PET Center received $102 million BRAIN Initiative grant to build new scanner

On Oct. 2, 2020, Yale scientists announced construction of the next-generation human brain PET scanner, the NeuroeXplorer (NX),…

Read More Yale PET Center received $102 million BRAIN Initiative grant to build new scannerContinue

WHO welcomed $90 million contribution from Kingdom of Saudi Arabia to support COVID-19 global response
COVID-19 | WHO

WHO welcomed $90 million contribution from Kingdom of Saudi Arabia to support COVID-19 global response

On Oct. 2, 2020, the WHO and the Kingdom of Saudi Arabia signed a contribution agreement in the…

Read More WHO welcomed $90 million contribution from Kingdom of Saudi Arabia to support COVID-19 global responseContinue

Quidel received Emergency Authorization for rapid antigen ‘ABC test’ assay for Influenza A+B and COVID-19
Biotechnology | COVID-19 | Diagnostics | Infectious Disease | Influenza

Quidel received Emergency Authorization for rapid antigen ‘ABC test’ assay for Influenza A+B and COVID-19

On Oct. 2, 2020, Quidel announced that it had received Emergency Use Authorization from the U.S. Food and…

Read More Quidel received Emergency Authorization for rapid antigen ‘ABC test’ assay for Influenza A+B and COVID-19Continue

Humanigen announced COVID-19 case report demonstrated rapid resolution after single IND EUA of Lenzilumabル
COVID-19 | Life Science History

Humanigen announced COVID-19 case report demonstrated rapid resolution after single IND EUA of Lenzilumabル

On Oct. 2, 2020, Humanigen announced that a patient case report on the use of lenzilumabル in critical…

Read More Humanigen announced COVID-19 case report demonstrated rapid resolution after single IND EUA of LenzilumabルContinue

UConn funded five COVID-19 research projects, announced additional funding
Life Science History

UConn funded five COVID-19 research projects, announced additional funding

On Oct. 2, 2020, the Uconn Office of the Vice President for Research (OVPR) (OVPR) announced a new…

Read More UConn funded five COVID-19 research projects, announced additional fundingContinue

LabCorp COVID-19 molecular test innovation received FDA authorization
COVID-19 | FDA | Life Science History

LabCorp COVID-19 molecular test innovation received FDA authorization

On Oct. 2, 2020, LabCorp announced that it had received an Emergency Use Authorization (EUA) from the FDA…

Read More LabCorp COVID-19 molecular test innovation received FDA authorizationContinue

19 organizations from the healthcare community unite to form COVID-19 testing industry consortium
COVID-19 | Life Science History

19 organizations from the healthcare community unite to form COVID-19 testing industry consortium

On Oct. 1, 2020, widespread accurate testing for SARS-CoV-2, the virus that causes COVID-19, is one critical aspect…

Read More 19 organizations from the healthcare community unite to form COVID-19 testing industry consortiumContinue

Veklury (remdesivir) made available directly from distributor
COVID-19 | Life Science History

Veklury (remdesivir) made available directly from distributor

On Oct. 1, 2020, american hospitals began purchasing Veklury (remdesivir) directly from the drugメs distributor. Veklury is an…

Read More Veklury (remdesivir) made available directly from distributorContinue

Gilead Sciences updated supply and distribution of Vekluryᆴ (remdesivir) in the US
COVID-19 | Life Science History

Gilead Sciences updated supply and distribution of Vekluryᆴ (remdesivir) in the US

On Oct. 1, 2020, Gilead Sciences announced that it will be responsible for distributing Veklury in the U.S….

Read More Gilead Sciences updated supply and distribution of Vekluryᆴ (remdesivir) in the USContinue

Amyris delivered sustainable alternative to shark squalene adjuvant enabling vaccines with no sharks killed
Biotechnology | COVID-19 | Infectious Disease | Marine Science | Vaccine

Amyris delivered sustainable alternative to shark squalene adjuvant enabling vaccines with no sharks killed

On Oct. 1, 2020, Amyris announced that it has begun delivering samples to pharmaceutical companies of a sustainable…

Read More Amyris delivered sustainable alternative to shark squalene adjuvant enabling vaccines with no sharks killedContinue

Johnson & Johnson completed acquisition of Momenta Pharmaceuticals for $65 billion
Biotechnology | Therapeutics

Johnson & Johnson completed acquisition of Momenta Pharmaceuticals for $65 billion

On Oct. 1, 2020, Johnson & Johnson announced it had successfully completed its acquisition of Momenta Pharmaceuticals, a…

Read More Johnson & Johnson completed acquisition of Momenta Pharmaceuticals for $65 billionContinue

Page navigation

Previous PagePrevious 1 … 16 17 18 19 20 … 76 Next PageNext
  • Categories
  • Timeline
  • Agriculture
  • Artificial Intelligence
  • Biology
  • Biotechnology
  • Cartoons – Historical
  • Cartoons – Original
  • CDC
  • CDMO
  • Chemical
  • Clinical Research
  • Cloning
  • CMO
  • COVID-19
  • CRISPR
  • CRO
  • Cryogenic
  • Dentistry
  • Diagnostics
  • Disease
  • Energy
  • Environmental
  • EPA
  • FDA
  • Forestry
  • Genomics
  • HIV
  • Infectious Disease
  • Influenza
  • IRB
  • Life Science History
  • Marine Science
  • Materials
  • Measles
  • Medical Device
  • Medicine
  • Nanotechnology
  • Neurology
  • NIH
  • Non-Profit Research
  • Nutraceuticals
  • Oncology
  • Ophthalmogy
  • Organ Transplant
  • Orthopedic
  • Other
  • Pharmaceutical
  • Plague
  • Polio
  • Prehistory
  • Radiology
  • Rare Disease
  • Stem Cell
  • Therapeutics
  • U.S. Congress
  • Uncategorized
  • USDA
  • Vaccine
  • Veterinary
  • WHO
  • Women's Health
  • 2025
  • 2024
  • 2023
  • 2022
  • 2021
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
  • 2014
  • 2013
  • 2012
  • 2011
  • 2010
  • 2009
  • 2008
  • 2007
  • 2006
  • 2005
  • 2004
  • 2003
  • 2002
  • 2001
  • 2000
  • 1999
  • 1998
  • 1997
  • 1996
  • 1995
  • 1994
  • 1993
  • 1992
  • 1991
  • 1990
  • 1989
  • 1988
  • 1987
  • 1986
  • 1985
  • 1984
  • 1983
  • 1982
  • 1981
  • 1980
  • 1979
  • 1978
  • 1977
  • 1976
  • 1975
  • 1974
  • 1973
  • 1972
  • 1971
  • 1970
  • 1969
  • 1968
  • 1967
  • 1966
  • 1965
  • 1964
  • 1963
  • 1962
  • 1961
  • 1960
  • 1959
  • 1958
  • 1957
  • 1956
  • 1955
  • 1954
  • 1953
  • 1952
  • 1951
  • 1950
  • 1949
  • 1948
  • 1947
  • 1946
  • 1945
  • 1944
  • 1943
  • 1942
  • 1941
  • 1940
  • 1939
  • 1938
  • 1937
  • 1936
  • 1935
  • 1934
  • 1933
  • 1932
  • 1931
  • 1930
  • 1929
  • 1928
  • 1927
  • 1926
  • 1925
  • 1924
  • 1923
  • 1922
  • 1921
  • 1920
  • 1919
  • 1918
  • 1917
  • 1916
  • 1915
  • 1914
  • 1913
  • 1912
  • 1911
  • 1910
  • 1909
  • 1908
  • 1907
  • 1906
  • 1905
  • 1904
  • 1903
  • 1902
  • 1901
  • 1900
  • 1899
  • 1898
  • 1897
  • 1896
  • 1895
  • 1894
  • 1893
  • 1892
  • 1891
  • 1890
  • 1889
  • 1888
  • 1887
  • 1886
  • 1885
  • 1884
  • 1883
  • 1882
  • 1881
  • 1880
  • 1879
  • 1878
  • 1877
  • 1876
  • 1875
  • 1874
  • 1873
  • 1872
  • 1871
  • 1870
  • 1869
  • 1868
  • 1867
  • 1866
  • 1865
  • 1864
  • 1863
  • 1862
  • 1861
  • 1860
  • 1859
  • 1858
  • 1857
  • 1856
  • 1855
  • 1854
  • 1853
  • 1852
  • 1851
  • 1850
  • 1849
  • 1848
  • 1847
  • 1846
  • 1845
  • 1844
  • 1843
  • 1842
  • 1840
  • 1839
  • 1838
  • 1837
  • 1836
  • 1834
  • 1833
  • 1832
  • 1831
  • 1830
  • 1828
  • 1827
  • 1826
  • 1825
  • 1824
  • 1823
  • 1820
  • 1819
  • 1818
  • 1817
  • 1816
  • 1813
  • 1811
  • 1810
  • 1809
  • 1808
  • 1804
  • 1802
  • 1801
  • 1800
  • 1799
  • 1798
  • 1796
  • 1795
  • 1794
  • 1793
  • 1790
  • 1789
  • 1788
  • 1786
  • 1785
  • 1784
  • 1782
  • 1781
  • 1777
  • 1769
  • 1765
  • 1761
  • 1753
  • 1751
  • 1749
  • 1747
  • 1746
  • 1743
  • 1741
  • 1738
  • 1727
  • 1723
  • 1721
  • 1720
  • 1718
  • 1716
  • 1712
  • 1697
  • 1693
  • 1683
  • 1674
  • 1667
  • 1666
  • 1665
  • 1664
  • 1663
  • 1658
  • 1656
  • 1647
  • 1636
  • 1634
  • 1629
  • 1621
  • 1603
  • 1580
  • 1521
  • 1510
  • 1403
  • 1377
  • 1370
  • 1363
  • 1348
  • 1346
  • 1322
  • 1285
  • 1202
  • 1200
  • 1179
  • 1100
  • 1050
  • 541
  • 470
  • 1
Subscribe to E-History

Subscribe

* indicates required

LifeScienceHistory.com

LifeScienceHistory.com Where history is made daily, is a comprehensive companion of life science. Simply put, we dig history and we mine data.

More

  • About
  • Life Science Heroes

Advertising

  • Life Science Banner Advertising
  • Advertise Your Life Science Jobs

Legal

  • Privacy Policy
  • Terms of Use

© 2025 LifeScienceHistory.com by James Web Design

Facebook Instagram Linkedin
  • Home
  • Directory
    • General Company Directory
    • CRO Directory
    • CMO Directory
    • Genealogy on Demand
  • Careers
    • Find Your Job
    • Advertise Your Life Science Jobs
  • News and History
  • Cartoons
  • Small World
  • Earth is a Rock
    • Earth is a Rock
    • Earth is a Rock Lyrics
    • Earth is a Rock Lyrics Defined
Search